Notification of Interest in Shares

RNS Number : 8685E

Alliance Pharma PLC

13 April 2011

 



For immediate release

13 April 2011

Alliance Pharma plc

TR-1: Notification of major interest in shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:			Alliance Pharma
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):	On market transfer between direct and indirect funds			√
3. Full name of person(s) subject to the notification obligation:		Aviva plc & its subsidiaries
4. Full name of shareholder(s)  (if different from 3.):		Registered Holder: BNY Norwich Union Nominees Limited      3,404,351*  Chase (GA Group) Nominees Limited       20,409,918* *denotes direct interest Chase Nominees Limited                                 502,486
5. Date of the transaction and date on which the threshold is crossed or reached:		12 April 2011
6. Date on which issuer notified:		12 April 2011
7. Threshold(s) that is/are crossed or reached:		7% to 10% Change at Direct Interest Level

8. Notified details:

A: Voting rights attached to shares

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

GB0031030819

Direct: 17,385,511 (7.36%) Indirect: 6,931,244 (2.93%)

Direct: 17,385,511 (7.36%) Indirect: 6,931,244 (2.93%)

24,316,755

23,814,269

502,486

10.07%

0.21%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

24,316,755

10.28%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:- Aviva Investors Global Services Limited: ·      Aviva plc (Parent Company) ·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc) ·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited) ·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
Proxy Voting:
10. Name of the proxy holder:		See Section 4
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Figures are based on a total number of voting rights of  236,614,917, as per the company's CULS Conversion and Additional Listing Announcement of 15 March 2011.
14. Contact name:	Neil Whittaker, Aviva plc
15. Contact telephone number:	01603 684420

 

END

 

 

HOLSFSFIDFFSEFL